Andreas Wicki, Director at Harmony Biosciences Holdings, Inc. (HRMY), sold 102,556 shares at $60.10 ($6.1M) on 2022-11-15, disclosed to the SEC on 2022-11-16.
Open-market sale of $6.1M HRMY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.10 | 40,317 | $2.4M | 39.2% |
| 2 | $59.10 | 40,317 | $2.4M | 39.2% |
| 3 | $60.10 | 10,961 | $659K | 10.8% |
| 4 | $60.10 | 10,961 | $659K | 10.8% |
| Total | $59.31 avg | 102,556 | $6.1M | 100% |
| Filing → |
| HRMY | SELL | 2022-11-10 | $15.2M | — | Filing → |
| HRMY | SELL | 2022-11-04 | $68.2M | — | Filing → |
| HRMY | SELL | 2022-08-10 | $62.2M | — | Filing → |